Head-to-head · Value Score
CoreAge Rx vs Invyncible
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, Invyncible a 68. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$99/mo
Save ~89% vs brand-nameInvyncible
#272 · Grade C · Watch List
Est. first month
From $149/mo (0.45 mg dose, compounded with glycine + B12)
Save ~86% vs brand-nameThe verdict
CoreAge Rx takes it on Value Score, 93 to 68 — an est. $99/mo first month, with no teaser step-up baked in. Invyncible isn't out of it: Someone who wants to read the price of every dose program, and the name of the pharmacy filling it, before handing over any details.
CoreAge Rx is also our overall #1 pick across the whole deals ranking — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | Invyncible |
|---|---|---|
| Value Score | 93 (A+) | 68 (C) |
| Est. first month | $99/mo | From $149/mo (0.45 mg dose, compounded with glycine + B12) |
| Save vs brand-name | ~89% | ~86% |
| Semaglutide | $99/mo | From $149/mo (0.45 mg dose, compounded with glycine + B12) |
| Tirzepatide | $149/mo | From $180/mo (2.5 mg weekly, 4-week program, compounded) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | 46 states plus DC |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Invyncible
Invyncible is a Florida-based telehealth brand operated by Nationwide Telemedicine, LLC, publishing every compounded semaglutide and tirzepatide program price on its open catalog across 46 states plus DC.
Why it's a deal
- Prices every dose program on the open catalog — no account, no intake, no quiz — and each product page re-prices as you change dose
- Names all six compounding pharmacies with street addresses and phone numbers, names the specific pharmacy on some product pages, and lets the patient choose which one fills the prescription
- Stocks FDA-approved brand Wegovy ($1,750) and Zepbound ($1,540) alongside compounded, and an oral semaglutide capsule program, each labeled as such on the catalog
- Refills are requested rather than auto-billed, and the card is only charged if a provider approves the prescription
- Names its operating company — Nationwide Telemedicine, LLC — states that the affiliated medical practices are independently owned, and publishes informed-consent, privacy, shipping and terms documents separately
The fine print
- Every price is shown against a permanent struck-through list figure, which is anchoring rather than a saving
- The entry figure is the smallest vial: plain compounded semaglutide runs $192.50, $262.50 and $350 across its three vial sizes, and the FAQ confirms cost rises with dose
- No 503A or 503B designation is given for any of the six named pharmacies
- The glycine + B12 program publishes no supply duration, so its figure cannot be converted to a monthly rate from the page
- Compounded semaglutide is unavailable in six more states than the company's 46-state footprint, and tirzepatide in seven
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to Invyncible.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.